ADC Therapeutics SA
(NYSE : ADCT)

( )
ADCT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.11%148.370.7%$877.32m
BMYBristol-Myers Squibb Co. -4.05%64.161.0%$804.09m
PFEPfizer Inc. -2.16%39.830.9%$667.18m
MRKMerck & Co., Inc. -2.93%85.970.7%$647.43m
ABBVAbbVie, Inc. -2.01%83.562.3%$617.98m
LLYEli Lilly & Co. -1.55%139.021.1%$425.04m
NVSNovartis AG -1.11%93.870.2%$145.91m
GSKGlaxoSmithKline Plc -1.22%47.240.2%$112.00m
APLSApellis Pharmaceuticals, Inc. -2.34%41.300.0%$110.32m
AZNAstraZeneca Plc -1.83%49.281.2%$101.75m
KRTXKaruna Therapeutics, Inc. 0.00%99.750.0%$73.45m
NVONovo Nordisk A/S -0.81%61.090.1%$72.43m
SNYSanofi -1.75%48.730.2%$63.37m
RETAReata Pharmaceuticals, Inc. -6.45%193.493.5%$59.40m
ENDPEndo International Plc -10.24%5.928.8%$43.86m

Company Profile

ADC Therapeutics Sarl develops antibody drug conjugates (ADCs) and non-antibody drug conjugate products. The company is based in Lausanne, Switzerland. ADC Therapeutics Sarl operates as a subsidiary of Celtic Therapeutics Holdings L.P.